MedPath

Comprehensive Cardiac CT Versus Exercise Testing in Suspected Coronary Artery Disease (2)

Phase 3
Completed
Conditions
Coronary Artery Disease
Stable Angina Pectoris
Interventions
Device: Cardiac CT scan
Registration Number
NCT02291484
Lead Sponsor
Erasmus Medical Center
Brief Summary

Multi-center, randomized-controlled trial comparing a comprehensive cardiac CT protocol with standard stress testing in patients with stable chest pain complaints.

Detailed Description

Rationale: CT calcium and coronary lumen imaging allow efficient exclusion of coronary artery disease (CAD), but cannot assess the hemodynamic significance of obstructive findings. Addition of stress myocardial perfusion imaging, which assesses the functional relevance of coronary narrowing, completes the non-invasive cardiac evaluation.

Hypothesis: A comprehensive cardiac CT examination will allow fast, accurate and complete evaluation of suspected CAD.

Objective: evaluate the effectiveness and efficiency of comprehensive cardiac CT workup of suspected CAD.

Study design: Open-labelled, randomized-controlled, clinical efficiency trial, with an intention-to-diagnose approach, between CT-guided management and the current standard of care (based on functional testing of provocable myocardial ischemia) in patients with suspected CAD.

Study population: 250 patients (\>18 yrs) with stable chest complaints, a \>10% pre-test probability of CAD, and referred for evaluation of possible CAD.

Intervention: Instead of the usual diagnostic approach, patients in the intervention group will undergo in sequence the following CT examinations: coronary calcium scan, coronary CT angiography and CT myocardial perfusion imaging, with completion dependent on results. Findings on CT will direct further management.

Main study parameters/endpoints:

Primary: Rate of negative invasive angiograms (as percentage of total population) Secondary: Diagnostic yield, chest complaints, quality of life, diagnostic and therapeutic procedures, overall costs and adverse events at 6 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Men and women aged >18 years.
  • Chest pain symptoms suspicious of coronary heart disease.
  • Pre-test probability of coronary artery disease >10%
Exclusion Criteria
  • History of CAD: prior myocardial infarction or revascularization procedure
  • Contra-indication to radiation exposure (CT/SPECT): pregnancy
  • Contra-indication to iodine contrast media: renal failure, iodine allergy
  • Contra-indications to adenosine
  • Inability or unwillingness to provide informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Comprehensive cardiac CTCardiac CT scanTiered cardiac CT protocol: 1. CT calcium scan 2. CT angiography (if calcium scan positive or high pre-test probability) 3. CT perfusion (if \>50% stenosis on CTA, or cannot be ruled out)
Primary Outcome Measures
NameTimeMethod
Rate of negative invasive angiograms (as percentage of total population)6 months

Number of performed invasive angiograms with no CAD requiring intervention

Secondary Outcome Measures
NameTimeMethod
Chest pain complaints6 months

Proportion of patients experiencing symptoms of chest pain

Quality of life6 months

Questionnaire based quality of life score

Major adverse event rate6 months

Death, myocardial infarction, unstable angina, urgent revascularizations, CVA

Radiation exposure6 months

Cumulative radiation dose from diagnostic and therapeutic interventions

Number of diagnostic and therapeutic procedures6 months

Number of diagnostic and therapeutic procedures

Medical expenses6 months

All medical expenses related to the diagnosis and treatment of suspected CAD

Trial Locations

Locations (4)

Erasmus MC

🇳🇱

Rotterdam, Netherlands

Maasstadziekenhuis

🇳🇱

Rotterdam, Netherlands

Albert Schweizerzieknhuis

🇳🇱

Dordrecht, Netherlands

Maastricht University Medical Center

🇳🇱

Maastricht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath